As a pleiotropic cytokine, IL-6 plays an important role as an inducer of hepatic acute phase responses, and one of the cytokine-targeted approaches for severe COVID-19 includes IL-6 blockade, however with modest clinical benefit. Here, IL6 is linked to COVID-19.